-
AstraZeneca Higher Off Drug News And Upgrade
Friday, December 9, 2016 - 12:47pm | 134AstraZeneca plc (ADR) (NYSE: AZN) shares are trading higher by $1.00 at $27.28 in Friday's session. The primary catalyst for the rally is the announcement that the FDA has accepted duravalumab for priority review status. Also, before the open, the company reported progress with it Alzheimer's drug...